Galanin/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors.
By using immunofluorescence methodology, extensive galanin (GAL) and GAL message-associated peptide (GMAP)-positive terminal networks were observed in the hippocampal formation. The majority of the GAL/GMAP fibers were dopamine beta-hydroxylase- (DBH) positive, that is, they were noradrenergic. This finding was established with GAL/GMAP-DBH double-staining and with 6-hydroxy-dopamine treatment, which totally abolished all fibers in which GAL/GMAP and DBH coexisted. Also, reserpine treatment caused a marked depletion of GAL. No evidence for GAL/GMAP coexistence with 5-hydroxytryptamine was obtained. In the ventral hippocampus, GAL/GMAP-, DBH-negative fibers were seen in the stratum oriens, the anterior stratum radiatum, along the granule cell layer and in the strata oriens and alveus. In the locus coeruleus (LC), around 80% of the GMAP-positive neurons contained neuropeptide tyrosine (NPY), and about 40% of the NPY-positive neurons expressed GMAP. GAL-R1 receptor mRNA was expressed in Barrington's nucleus (close to the LC), but was not detected in the hippocampal formation/dorsal cortical areas. GAL-R2 receptor mRNA was found in the granule cell layer in the dentate gyrus. The present results show that most, but not all, immunohistochemically detectable GAL/GMAP in the hippocampal formation/dorsal cortex is present in noradrenergic nerve terminals originating in the LC, which has a robust GAL/GMAP synthesis. The functional role of GAL may be related to noradrenaline, possibly by a presynaptic action. However, the presence of GAL in other systems and of GAL-R2 receptor mRNA in granule cells also indicates other targets.
Xu
Z Q
ZQ
Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Shi
T J
TJ
Hökfelt
T
T
D000818:Animals; D002540:Cerebral Cortex / Q000166:cytology / Q000378:metabolism*; D004299:Dopamine beta-Hydroxylase / Q000032:analysis; D005455:Fluorescent Antibody Technique; D019004:Galanin / Q000032:analysis / Q000096:biosynthesis*; D006624:Hippocampus / Q000378:metabolism* / Q000648:ultrastructure; D017403:In Situ Hybridization; D008125:Locus Coeruleus / Q000166:cytology / Q000378:metabolism*; D008297:Male; D009412:Nerve Fibers / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D009478:Neuropeptide Y / Q000032:analysis / Q000096:biosynthesis*; D009638:Norepinephrine / Q000032:analysis*; D051381:Rats; D017207:Rats, Sprague-Dawley; D044088:Receptors, Galanin; D011964:Receptors, Gastrointestinal Hormone / Q000032:analysis / Q000096:biosynthesis*; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000032:analysis
D009478:Neuropeptide Y; D044088:Receptors, Galanin; D011964:Receptors, Gastrointestinal Hormone; C078371:galanin message-associated peptide; D012701:Serotonin; D019004:Galanin; D012110:Reserpine; D004299:Dopamine beta-Hydroxylase; D009638:Norepinephrine